A Phase I, Single Center, Randomized, Double-Blind, Three-Period Crossover Study Assessing Pharmacokinetics, Safety and Tolerability of Multiple Oral Omadacycline Regimens in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 04 Dec 2017

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Omadacycline (Primary)
Indications Bacterial infections; Community-acquired pneumonia; Skin and soft tissue infections
Focus Adverse reactions; Pharmacokinetics

04 Dec 2017 New trial record
27 Nov 2017 Results published in the Antimicrobial Agents and Chemotherapy Journal.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com